Title : Disentangling conflicting evidence on DPP-4 inhibitors and outcomes of COVID-19: narrative review and meta-analysis - Bonora_2021_J.Endocrinol.Invest__1 |
Author(s) : Bonora BM , Avogaro A , Fadini GP |
Ref : J Endocrinol Invest , :1 , 2021 |
Abstract : |
PubMedSearch : Bonora_2021_J.Endocrinol.Invest__1 |
PubMedID: 33512688 |
Title : The pleiotropic cardiovascular effects of dipeptidyl peptidase-4 inhibitors - Avogaro_2018_Br.J.Clin.Pharmacol_84_1686 |
Author(s) : Avogaro A , Fadini GP |
Ref : British Journal of Clinical Pharmacology , 84 :1686 , 2018 |
Abstract : |
PubMedSearch : Avogaro_2018_Br.J.Clin.Pharmacol_84_1686 |
PubMedID: 29667232 |
Title : Dipeptidyl peptidase-4 inhibition and vascular repair by mobilization of endogenous stem cells in diabetes and beyond - Fadini_2013_Atherosclerosis_229_23 |
Author(s) : Fadini GP , Avogaro A |
Ref : Atherosclerosis , 229 :23 , 2013 |
Abstract : |
PubMedSearch : Fadini_2013_Atherosclerosis_229_23 |
PubMedID: 23643052 |
Title : The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha - Fadini_2010_Diabetes.Care_33_1607 |
Author(s) : Fadini GP , Boscaro E , Albiero M , Menegazzo L , Frison V , de Kreutzenberg S , Agostini C , Tiengo A , Avogaro A |
Ref : Diabetes Care , 33 :1607 , 2010 |
Abstract : |
PubMedSearch : Fadini_2010_Diabetes.Care_33_1607 |
PubMedID: 20357375 |